Trump accuses the FDA of DELAYING approval of coronavirus vaccines until after the election

President Donald Trump has lashed out at the Food and Drug Administration, accusing the agency of attempting to delay approval for coronavirus vaccines and treatments until after the presidential election. ‘The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the … Read more

Imperial College vaccine’s second round trials on 200 humans

University of Oxford Oxford University academics began developing the ChAdOx1 nCoV-19 vaccine in January. It is now named AZD1222, after the researchers signed a manufacturing partnership with pharmaceutical giant AstraZeneca. Human trials started on April 23 and they are now in the final phase, with trials being carried out in the UK, Brazil and South … Read more

Coronavirus UK: Pharmacists will be able to give out vaccines

Pharmacists will be able to give out Covid-19 jabs to speed up a nation-wide roll out, Matt Hancock has revealed.  The Health Secretary claimed pharmacists in Britain would play a ‘massive role’ when Number 10 has a coronavirus vaccination programme. High street pharmacies are already able to give out jabs for the flu, chickenpox, HPV, … Read more

Covid-19 vaccines prove successful in pre-animal trial lab tests

Two possible vaccines to tackle Covid-19 in animals have proved successful in laboratory tests, scientists say.  In-vitro trials have shown the two vaccine candidates, developed by UK-based firm The Vaccine Group, induced immunity at sites where the coronavirus replicates.  The trials were conducted outside the animal – a process known as ‘in vitro’ – rather than … Read more

Rival vaccines being developed by Oxford and Imperial may be combined to beat coronavirus

Rival vaccines being developed by Oxford and Imperial may be combined to beat coronavirus, expert says Oxford University’s vaccine is already being tested on at least 1,000 people Professor Robin Shattock said they could well be used together because the way they work differs  Scientists increasingly think booster jabs will be needed to maintain protection  … Read more

Coronavirus’ slow mutation will make vaccines more effective

Health experts say the novel coronavirus is mutating at a slower rate than several other respiratory viruses.  The virus has already undergone about two dozen genetic changes, leading many to fear that an even deadlier strain is around the corner. However, scientists say that the mutations don’t vary much from the virus that originated in … Read more

China offering coronavirus candidate vaccines to state…

China is offering unproven coronavirus vaccines to citizens travelling abroad because the virus is petering out in the country, it emerged today.  Employees at large state-run companies going abroad for work are being recruited to take one of two vaccines developed by the China National Biotec Group.   China desperately wants to become the first country to … Read more

Scientists are testing MMR vaccines to prevent sepsis that kills many COVID-19 sufferers 

Could a measles shot reduce deadly inflammation in coronavirus patients? Scientists are testing MMR vaccines to prevent sepsis that kills many COVID-19 sufferers MMR and tuberculosis vaccines generate anti-inflammatory immune responses COVID-19 patients immune systems often overreact to the virus that causes the disease, triggering out-of-control inflammation and sepsis  Mice given sepsis and an MMR … Read more

Vaccines could soon be stored for up to three years

Many of the world’s most vulnerable children are currently miss out on life-saving vaccinations because the jabs rapidly spoil if not refrigerated.  However, a recent breakthrough in vaccine preservation could allow the crucial jabs to be stored at room temperature for up to three years without losing effectiveness.  This will allow medics to distribute the … Read more

Coronavirus: ‘Several’ vaccines could be ready by end of year

Multiple coronavirus vaccines could be ready for mass-use by the end of this year, according to a British pharmaceutical giant. AstraZeneca said it was on track to produce millions of its experimental COVID-19 jab – called AZD1222 – by September.   The jab, developed by scientists at Oxford University, has moved into larger human trials after showing promise … Read more